Characteristics of cerebrospinal fluid biomarkers/ imaging findings in patient with amyloid‐negative dementia ∼second report∼
Naoto Takenoshita, Shoya Inagawa, Ryo Yamamoto, Haruo Hanyu, Kensaku Kasuga, Takeshi Ikeuchi, Kenji Ishii, Soichiro Shimizu · 2025
Read Characteristics of cerebrospinal fluid biomarkers/ imaging findings in patient with amyloid‐negative dementia ∼second report∼ by Naoto Takenoshita, Shoya Inagawa, Ryo Yamamoto, Haruo Hanyu, Kensaku Kasuga, Takeshi Ikeuchi, Kenji Ishii, Soichiro Shimizu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714555.txt.
Description
Naoto Takenoshita and co-authors examine dementia cases that test negative for amyloid in a 2025 clinical report, their second on the topic. Many patients labeled with Alzheimer's disease show atypical symptoms or scans, so the team checked who among them truly carries the disease's signature protein buildup.
Eighty-five patients received both amyloid imaging and spinal fluid tests, splitting into positive and negative groups of similar size. Spinal fluid markers differed sharply between the groups, as expected. Brain shrinkage patterns did not separate them, but blood flow scans showed distinct drops in the parietal lobe and precuneus. The report refines how clinicians read mixed signals.
Catalog record
| CREATOR | Naoto Takenoshita, Shoya Inagawa, Ryo Yamamoto, Haruo Hanyu, Kensaku Kasuga, Takeshi Ikeuchi, Kenji Ishii, Soichiro Shimizu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |